Home > Insider Trading > Filing (0001415889-24-012265)

Filing Details

Accession Number:: 0001415889-24-012265
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-05-03 21:35:13
Reporting Period:: 2024-05-01

Accepted Time:: 2024-05-03 21:35:13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1604821	Natera Inc.	NTRA	Services-Medical Laboratories (8071)	010894487

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1697362	Burkes Michael Brophy	C/O Natera, Inc. 13011 Mccallen Pass Building A Suite 100 Austin TX 78753	Chief Financial Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2024-05-01	400	$92.60	69,008	No	4	S	Direct
Common Stock	Disposition	2024-05-01	866	$93.88	68,142	No	4	S	Direct
Common Stock	Disposition	2024-05-01	400	$94.70	67,742	No	4	S	Direct
Common Stock	Disposition	2024-05-01	200	$95.64	67,542	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.20 to $93.05 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.34 to $94.31 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.39 to $94.96 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.50 to $95.78 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.